FOXO TECHNOLOGIES INC. Increase (Decrease) in Accounts Receivable
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Accounts Receivable of $1.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $228.17K, a 89.93% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $1.44M, a 275.60% increase year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$692.40K, a 620.26% decline year-over-year.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$1.84M.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts receivable for fiscal 2025 was $119.05K.
- FOXO TECHNOLOGIES INC. increase (decrease) in accounts receivable for fiscal 2024 was -$553.93K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $228.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.67M 10-Q · filed 2026-08-14 | $977.85K derived: sum of 3 quarters · filed 2026-08-14 | -$860.82K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-15 | $749.68K derived: sum of 2 quarters · filed 2026-05-15 | -$1.09M derived: sum of 3 quarters · filed 2026-05-15 | $1.18M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$692.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$2.53M derived: sum of 2 quarters · filed 2026-04-15 | -$264.89K derived: sum of 3 quarters · filed 2026-08-14 | $119.05K 10-K · filed 2026-04-15 | |
| 2025-09-30 | -$1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $427.51K derived: sum of 2 quarters · filed 2026-08-14 | $811.45K 10-Q · filed 2025-11-10 | $944.54K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.65M 10-Q · filed 2026-08-14 | $2.78M derived: sum of 3 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $383.94K 10-Q · filed 2026-05-15 | $517.03K derived: sum of 2 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $133.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$553.93K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | -$687.02K 10-Q · filed 2025-11-10 | -$687.00K 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |